NOT
FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART,
DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO
DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR
REGULATIONS OF SUCH JURISDICTION
FOR
IMMEDIATE RELEASE
10 February 2025
RECOMMENDED CASH AND SHARE
OFFER
For Direct Line insurance
group plc ("Direct line")
BY AVIVA PLC ("AVIVA")
to be effected by means of a Scheme of
Arrangement
under Part 26 of the Companies Act 2006
PUBLICATION OF THE SCHEME
DOCUMENT
On 23 December 2024, the boards of directors of
Aviva and Direct Line announced that they had reached agreement on
the terms of a recommended cash and share offer for the entire
issued and to be issued share capital of Direct Line (the
"Acquisition"), to be
implemented by way of a court-sanctioned scheme of arrangement
under Part 26 of the Companies Act (the "Scheme").
Publication of
the Scheme Document
Direct Line and Aviva are pleased to announce
that a circular in relation to the Scheme (the "Scheme Document") has been published
today by Direct Line, setting out, among other things, a letter
from the Chair of Direct Line, an explanatory statement pursuant to
section 897 of the Companies Act, the full terms and conditions of
the Scheme, an expected timetable of principal events, notices of
the Court Meeting and the General Meeting and details of the
actions to be taken by Direct Line Shareholders.
The Scheme Document will be made available,
subject to certain restrictions relating to persons resident in
Restricted Jurisdictions, on Direct Line's website at
https://www.directlinegroup.co.uk/en/investors
and on Aviva's website at
https://www.aviva.com/investors/offer-for-direct-line-insurance-group-plc/
by no later than 12 noon on 11 February 2025.
Hard copies of the Scheme Document (or,
depending on Direct Line Shareholders' communication preferences, a
letter or email giving details of the website where the Scheme
Document may be accessed) and Forms of Proxy for the Court Meeting
and the General Meeting are being sent to Direct Line Shareholders
today, subject to certain restrictions relating to persons resident
in Restricted Jurisdictions.
Capitalised terms used in this announcement
shall, unless otherwise defined, have the same meanings as set out
in the Scheme Document. All references to times in this
announcement are to London, United Kingdom times unless stated
otherwise.
The Acquisition constitutes a "significant
transaction" for Aviva for the purposes of the Listing Rules and
the 2.7 Announcement constituted a notification pursuant to Chapter
7 of the Listing Rules. Certain further information required to be
notified by Aviva pursuant to Chapter 7 of the Listing Rules is set
out in paragraphs 9, 10 and 14.2 of Part VII (Additional Information on Direct Line and
Aviva) of the Scheme Document. The Acquisition does not
require separate approval by Aviva Shareholders.
As required by Rule 28 of the Takeover Code,
the Aviva 2025 Profit Forecast and Aviva 2026 Profit Forecast are
set out in the Scheme Document (see paragraph 10 of Part I
(Letter from the Chair of Direct
Line) on
page 27 of the
Scheme Document and Appendix II (Aviva Profit Forecasts) on
pages 121 to 127 of
the Scheme Document).
Action
required
As further detailed in the Scheme Document, in
order to become Effective, the Scheme will require, among other
things, that the requisite majority of: (i) Scheme Shareholders
vote in favour of the Scheme at the Court Meeting; and (ii) Direct
Line Shareholders vote in favour of the Special Resolution at the
General Meeting.
The approval required at the Court Meeting for
approval of the Scheme is a majority in number of the Scheme
Shareholders who are present and vote, whether in person or by
proxy, at the Court Meeting and who represent 75 percent or more in
value of the Scheme Shares voted by those Scheme Shareholders. The
approval required at the General Meeting for the Special Resolution
to be passed is at least 75 percent of the votes cast (in person or
by proxy).
Notices convening the Court Meeting and the
General Meeting to be held at Riverbank House, 2 Swan
Lane, London, EC4R 3AD at 11.00 a.m. and 11.15 a.m.
(or as soon thereafter as the Court Meeting concludes or is
adjourned) on 10 March 2025,
respectively, are set out in the Scheme Document.
Any changes to the arrangements for the Court
Meeting and the General Meeting will be communicated to Direct Line
Shareholders before the relevant Meeting, through Direct Line's
website https://www.directlinegroup.co.uk/en/investors
and by announcement through a Regulatory Information
Service.
It is important that, for the Court Meeting in
particular, as many votes as possible are cast so that the Court
may be satisfied that there is a fair representation of opinion of
Scheme Shareholders.
Scheme Shareholders and Direct Line
Shareholders are therefore strongly urged to submit proxy
appointments and instructions for the Court Meeting and the General
Meeting as soon as possible and, in any event, so that the proxy
appointment and instructions are received by Computershare Investor
Services PLC ("Computershare") no later than 48
hours before the relevant Meeting (or, in the case of
any adjournment, not later than 48 hours before the time fixed for
the adjourned Meeting, in each case excluding any part of such 48
hour period falling on a day that is not a working
day). Further detail on the deadlines for appointing
proxies are set out in the Appendix to this announcement and in the
Scheme Document.
Timetable
The Scheme Document contains an expected
timetable of principal events in relation to the Scheme, which is
also set out in the Appendix to this announcement. The Scheme
remains conditional on the approval of the requisite majority of
Scheme Shareholders at the Court Meeting and the requisite majority
of Direct Line Shareholders at the General Meeting. The Scheme is
also subject to the satisfaction (or, where applicable, waiver) of
the other Conditions (including the sanction of the Court) and
further terms, as described more fully in the Scheme
Document.
The Scheme is expected to become Effective in
mid-2025 and, in any event, prior to the Long Stop Date. Direct
Line will make further announcements through a Regulatory
Information Service, with such announcements also being made
available on Direct Line's website at https://www.directlinegroup.co.uk/en/investors
and on Aviva's website at
https://www.aviva.com/investors/offer-for-direct-line-insurance-group-plc/.
An update to the expected timetable is expected to be announced
following receipt of the relevant regulatory approvals upon which
the Acquisition is conditional.
Recommendation
The Direct Line Directors, who have been so
advised by Morgan Stanley & Co., Robey Warshaw and RBC Capital
Markets as to the financial terms of the Acquisition, consider the
terms of the Acquisition to be fair and reasonable. In providing
their advice to the Direct Line Directors, Morgan Stanley &
Co., Robey Warshaw and RBC Capital Markets have taken into account
the commercial assessments of the Direct Line Directors. Morgan
Stanley & Co. and Robey Warshaw are providing independent
financial advice to the Direct Line Directors for the purposes of
Rule 3 of the Takeover Code.
The Direct Line Directors consider that the
terms of the Acquisition are in the best interests of Direct Line
Shareholders as a whole. Accordingly, the Direct Line Directors
unanimously recommend that Scheme Shareholders vote in favour of
the Scheme at the Court Meeting and that Direct Line Shareholders
vote in favour of the Special Resolution to be proposed at the
General Meeting, as those Direct Line Directors who (or whose
immediate family) beneficially hold Direct Line Shares have
irrevocably undertaken to do (or procure to be done) in respect of
their entire beneficial holdings.
Direct Line Shareholders should carefully read
the Scheme Document in its entirety before making a decision with
respect to the Scheme.
Additional
Information for Direct Line Shareholders
If you have any questions about this
announcement, the Scheme Document, the Court Meeting or the General
Meeting, or are in any doubt as to how to complete and return the
Forms of Proxy or to submit your proxies electronically or online,
please contact Direct Line's Registrars, Computershare, by calling
the Shareholder Helpline on +44 (0)370 873 5880. Lines are open
between 8.30 a.m. and 5.30 p.m. Monday to Friday (except public
holidays in England and Wales). Please use the country code when
calling from outside the UK. Calls from outside the UK will be
charged at the applicable international rate. Different charges may
apply to calls from mobile telephones. Please note that calls may
be monitored or recorded and Direct Line's Registrars,
Computershare, cannot provide advice on the merits of the
Acquisition or the Scheme or give any financial, legal or tax
advice.
A copy of the Scheme Document will be submitted
to the National Storage Mechanism and will be available for
inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
If the Scheme is sanctioned as outlined above,
it is expected that the last day of dealings in Direct Line Shares
on the Main Market of the London Stock Exchange will be
on the date of the Court Sanction Hearing, such that no
transfers of Direct Line Shares will be
registered after 6.00 p.m. on that date (other than the
registration of the transfer of the Direct Line
Shares to Aviva pursuant to the Scheme).
Following this, all of the Direct Line Shares will be
suspended from the Official List and from trading on the London
Stock Exchange's Main Market for listed securities, and Direct Line
Shares will be disabled in CREST.
Aviva
|
|
Media
|
|
Andrew Reid
|
+44 (0)7800 694 276
|
Sarah Swailes
|
+44 (0)7800 694 859
|
Investors and analysts
|
|
Greg Neilson
|
+44 (0)7800 694 564
|
Joel von Sternberg
|
+44 (0)7384 231 238
|
Michael O'Hara
|
+44 (0)7387 234 388
|
Citi (Joint
Financial Adviser and Joint Corporate Broker to
Aviva)
|
Peter Brown / Sian Evans / Peter Catterall /
Michael Lamb
|
+44 (0)20 7986 4000
|
Goldman Sachs
International (Joint Financial Adviser and Joint Corporate Broker
to Aviva)
|
Anthony Gutman / Nimesh Khiroya / Bertie
Whitehead
|
+44 (0)20 7774 1000
|
|
|
Direct
Line
|
|
Media
|
|
Roger Lowry (Director of Corporate
Affairs)
|
+44 (0)7881 553 155
|
Investors and analysts
|
|
Dhruv Gahlaut, CFA (Chief Strategy &
Investor Relations Officer)
|
+44 (0)7385 481177
|
|
|
Morgan Stanley
& Co. (Joint Lead Financial Adviser and Joint Corporate Broker
to Direct Line)
|
Ben Grindley / Laurence Hopkins / Melissa Godoy
/ Jonathan Gold
|
+44 (0) 20 7425 8000
|
Robey Warshaw
(Joint Lead Financial Adviser to Direct Line)
|
Simon Robey / Chetan Singh / Kunal
Ranpara
|
+44 (0) 20 7317 3999
|
RBC Capital
Markets (Joint Financial Adviser and Joint Corporate Broker to
Direct Line)
|
|
Oliver Hearsey / Daniel Ohana / Elliot
Thomas
|
+44 (0) 20 7653 4000
|
Brunswick
Group (PR Adviser to Direct Line)
|
|
Tom Burns / Diana Vaughton / Freya
Semken
|
+44 (0)20 7404 5959
|
Enquiries:
Slaughter and May is acting as legal adviser to
Direct Line and Clifford Chance LLP is acting as legal adviser to
Aviva.
APPENDIX
EXPECTED TIMETABLE
OF PRINCIPAL EVENTS
The following indicative timetable is based
on Direct Line's and Aviva's current
expected dates for the implementation of the Scheme and is subject
to change. If any of the dates and/or times in this expected
timetable change, the revised dates and/or times will be notified
to Direct Line Shareholders by
announcement through the Regulatory Information Service of the
London Stock Exchange.
Event
|
Time and/or date (1)
|
Publication of the Scheme Document
|
10 February
2025
|
Latest time for lodging Forms of Proxy for
the:
|
|
Court Meeting (BLUE form)
|
11.00 a.m. on 6 March
2025 (2)
|
General Meeting (WHITE form)
|
11.15 a.m. on 6 March
2025 (3)
|
Voting Record Time
|
6.00 p.m. on 6 March
2025 (4)
|
Court
Meeting
|
11.00 a.m. on 10 March
2025
|
General
Meeting
|
11.15 a.m. on 10 March
2025 (5)
|
The
following dates and times associated with the Scheme are indicative
only and subject to change and will depend on, among other things,
the date on which the Conditions to the Scheme are satisfied or, if
capable of waiver, waived, and the date on which the Court
sanctions the Scheme. Direct Line will give adequate notice of any
changes to these dates and times, when known, by issuing an
announcement through a Regulatory Information Service, with such
announcement being made available on Direct Line's website
at https://www.directlinegroup.co.uk/en/investors. See also note
(1).
|
Court Sanction Hearing
|
a date expected to be
in mid-2025, subject to the satisfaction (or, if applicable,
waiver) of the relevant Conditions and, in any event, prior to the
Long Stop Date ("D")
|
Last day for dealings in, and for the
registration of transfer of, and disablement in CREST of, Direct
Line Shares
|
D*
|
Scheme Record Time
|
6.00 p.m. on D*
(6)
|
Suspension of trading, and
dealings in, Direct Line Shares
|
7.30 a.m. on
D+1*
|
Effective Date
|
D+1* (7)
|
Cancellation of listing of Direct Line Shares
on the Official List and of trading of Direct Line Shares on the
London Stock Exchange
|
by 8.00 a.m. on
D+2*
|
New Aviva Shares to be issued to Direct Line
Shareholders
|
by 8.00 a.m. on
D+2*
|
Admission of New Aviva Shares and commencement
of dealings in New Aviva Shares on the London Stock
Exchange
|
by 8.00 a.m. on
D+2*
|
CREST accounts of Direct Line Shareholders
credited with New Aviva Shares
|
on or as soon as
possible after
8:00 a.m. on D+2* but not later than 14 days after the Effective
Date
|
CREST accounts of Direct Line Shareholders
credited with: (i) the cash element of the Offer Consideration; and
(ii) any cash due in relation to the sale of fractional
entitlements
|
within 14 days after
the Effective Date
|
Despatch of share certificates for New Aviva
Shares and of cheques for, or initiation of electronic payments in
respect of: (i) the cash element of the Offer Consideration; and
(ii) any cash due in relation to the sale of fractional
entitlements for those Direct Line Shareholders who do not hold
their Direct Line Shares in CREST, or, where applicable, the
despatch of cheques for the cash due to Restricted Shareholders
under the Scheme
|
within 14 days after
the Effective Date
|
Long Stop Date
|
31 December 2025
(8)
|
Notes:
(1) The dates and times are indicative only and
are based on current expectations and may be subject to change and
will depend on, among other things, the date on which the
Conditions to the Scheme are satisfied or, if capable of waiver,
waived, and the date on which the Court sanctions the Scheme.
References to times are to London, United Kingdom time unless
otherwise stated. If any of the times and/or dates above change,
the revised times and/or dates will be notified to Direct Line
Shareholders by announcement through a Regulatory Information
Service.
Participants in the Direct Line Share Plans will be contacted
separately and details of the effect of the Scheme on their rights
under the Direct Line Share Plans, including details of any dates
and times relevant to them, will be provided on the EquatePlus
portal used in connection with the Direct Line Share
Plans.
(2) It is requested that BLUE Forms of Proxy for
the Court Meeting be lodged not later than 48 hours prior to the
time appointed for the Court Meeting or, if the Court Meeting is
adjourned, 48 hours prior to the time fixed for any adjourned Court
Meeting (excluding any part of such 48 hour period falling on a day
that is not a working day). If the BLUE Form of Proxy for the Court
Meeting is not lodged by 11.00 a.m. on 6 March 2025, it may be
presented in person to the Computershare representative who will be
present at the Court Meeting or to the Chair of the Court Meeting,
at any time prior to the commencement of the Court Meeting (or any
adjournment thereof).
(3) In order to be valid, the WHITE Forms of Proxy
for the General Meeting must be lodged not later than 11.15 a.m. on
6 March 2025 or, if the General Meeting is adjourned, 48 hours
prior to the time fixed for the adjourned General Meeting
(excluding any part of such 48 hour period falling on a day that is
not a working day).
(4) If either the Court Meeting or the General
Meeting is adjourned, the Voting Record Time for the relevant
adjourned Meeting will be 6.00 p.m. on the day which is two
Business Days prior to the date of the adjourned
Meeting.
(5) To commence at the time fixed or as soon
thereafter as the Court Meeting concludes or is
adjourned.
(6) Scheme Shareholders who are on the Register at
this time are entitled to receive the Offer Consideration under the
Acquisition.
(7) The Scheme shall become Effective as soon as a
copy of the Court Order has been delivered to the Registrar of
Companies. This is expected to occur following the Scheme Record
Time and after the suspension of trading in Direct Line Shares. The
events which are stated as occurring on subsequent dates are
conditional on the Effective Date and operate by reference to that
date.
(8) This is the latest date by which the Scheme
may become Effective unless there is a Phase 2 CMA Reference and
the Condition set out in paragraph 3(c)(i) of Part III (Conditions
to the Implementation of the Scheme and to the Acquisition) of the
Scheme Document has not been waived or invoked by Aviva, in which
case the Long Stop Date will be extended to 27 October 2026. In
either case, the Long Stop Date may be extended to such later date
as may be agreed in writing by Aviva and Direct Line (with the
Panel's consent and Court approval (if such approval(s) are
required)).
* All dates by reference to
"D+1" and "D+2" will be to the date falling the number of indicated
Business Days immediately after the actual date, which is "D", as
indicated above.
Further
information
This announcement is for information purposes only and is not
intended to and does not constitute, or form part of, any offer to
sell or an invitation to purchase any securities; a solicitation of
an offer to buy, otherwise acquire, subscribe for, sell or
otherwise dispose of any securities pursuant to the Acquisition or
otherwise; or the solicitation of any vote or approval in any
jurisdiction pursuant to the Acquisition or otherwise; nor shall
there be any purchase, sale, issuance or exchange of securities or
such solicitation in any jurisdiction in which such offer,
solicitation, sale issuance or exchange is
unlawful.
The Acquisition will be made solely by means of the Scheme
Document (or, if the Acquisition is implemented by way of a
Takeover Offer, the offer document) which, together with any
related Forms of Proxy, will contain the full terms and conditions
of the Acquisition, including details of how to vote in respect of
the Scheme. Any decision in respect of, or other response to, the
Acquisition should be made only on the basis of the information
contained in the Scheme Document (or, if the Acquisition is
implemented by way of a Takeover Offer, the offer
document).
The statements contained in this announcement are made as at
the date of this announcement, unless some other time is specified
in relation to them, and publication of this announcement shall not
give rise to any implication that there has been no change in the
facts set forth in this announcement since such
date.
This announcement does not constitute a prospectus or
prospectus equivalent document.
Important notices about
financial advisers
Citi, which is authorised by the PRA and regulated in the
United Kingdom by the PRA and FCA is acting as financial adviser
exclusively for Aviva and for no one else in connection with the
matters described in this announcement, and will not be responsible
to anyone other than Aviva for providing the protections afforded
to its clients nor for providing advice in relation to the matters
referred to in this announcement. Neither Citi nor any of its
affiliates, directors or employees owes or accepts any duty,
liability or responsibility whatsoever (whether direct or indirect,
consequential, whether in contract, tort, in delict, under statute
or otherwise) to any person who is not a client of Citi in
connection with this announcement, any statement contained herein
or otherwise.
Goldman Sachs International, which is authorised by the PRA
and regulated by the PRA and the FCA in the United Kingdom, is
acting exclusively for Aviva and no one else in connection with the
matters referred to in this announcement and will not be
responsible to anyone other than Aviva for providing the
protections afforded to clients of Goldman Sachs International, or
for providing advice in connection with the matters referred to in
this announcement.
Morgan Stanley & Co., which is authorised
by the PRA and
regulated by the PRA and the FCA in the United Kingdom, is acting
exclusively for Direct Line and for no one else in connection with
the Acquisition and neither Morgan Stanley & Co. nor any of its
affiliates, nor their respective directors, officers, employees or
agents will be responsible to anyone other than Direct Line for
providing the protections afforded to its clients or for providing
advice in relation to the Acquisition or the contents of this
announcement.
Robey Warshaw which is authorised and regulated in the United
Kingdom by the FCA, is acting as financial adviser exclusively for
Direct Line and no one else in connection with the matters referred
to in this announcement and will not regard any other person as its
client in relation to the matters referred to in this announcement
and will not be responsible to anyone other than Direct Line for
providing the protections afforded to clients of Robey Warshaw, nor
for providing advice in relation to the matters referred to in this
announcement.
RBC Capital Markets which is
authorised by the PRA and regulated by the PRA and the FCA in the
United Kingdom, is acting exclusively for Direct Line and for no
one else in connection with the Acquisition and neither RBC Capital
Markets nor any of its affiliates, nor their respective directors,
officers, employees or agents will be responsible to anyone other
than Direct Line for providing the protections afforded to its
clients or for providing advice in relation to the Acquisition, the
contents of this announcement or any other matters referred to in
this announcement.
Overseas
shareholders
The release, publication or distribution of this announcement
in, into or from jurisdictions other than the United Kingdom, and
the availability of the Acquisition to Direct Line Shareholders who
are not resident in the United Kingdom, may be restricted by the
laws of those jurisdictions and therefore persons into whose
possession this announcement comes should inform themselves about
and observe such restrictions. In particular, the ability of
persons who are not resident in the United Kingdom to vote their
Direct Line Shares with respect to the Scheme at the Court Meeting
and/or General Meeting, or to execute and deliver forms of proxy
appointing another to vote at the Court Meeting and/or General
Meeting on their behalf, may be affected by the laws of the
relevant jurisdictions in which they are located. Any failure to
comply with any such restrictions may constitute a violation of the
securities laws of any such jurisdiction. To the fullest extent
permitted by applicable law, the companies and persons involved in
the Acquisition disclaim any responsibility or liability for the
violation of such restrictions by any person.
Unless otherwise determined by Aviva or required by the
Takeover Code, and permitted by applicable law and regulation, the
Acquisition will not be made available, directly or indirectly, in,
into or from a Restricted Jurisdiction. Accordingly, copies of this
announcement and all documents relating to the Acquisition are not
being, and must not be, directly or indirectly, mailed or otherwise
forwarded, distributed or sent in, into or from a Restricted
Jurisdiction, and persons receiving this announcement and all
documents relating to the Acquisition (including custodians,
nominees and trustees) must not mail or otherwise distribute or
send them in, into or from such Restricted Jurisdiction. If the
Acquisition is implemented by way of Takeover Offer (unless
otherwise permitted by applicable law or regulation), the Takeover
Offer may not be made, directly or indirectly, in or into, or by
use of mails or any other means or instrumentality (including,
without limitation, facsimile, e-mail or other electronic
transmission, telex or telephone) of interstate or foreign commerce
of, or any facility of a national, state or other securities
exchange of any Restricted Jurisdiction and the Takeover Offer will
not be capable of acceptance by any such use, means,
instrumentality or facilities or from within any Restricted
Jurisdiction.
This announcement has been prepared in connection with
proposals in relation to a scheme of arrangement pursuant to and
for the purpose of complying with English law and the Takeover Code
and information disclosed may not be the same as that which would
have been disclosed if this announcement had been prepared in
accordance with the laws of jurisdictions outside the United
Kingdom. Nothing in this announcement should be relied on for any
other purpose. Overseas Shareholders should consult their own
professional advisers with respect to the legal and tax
consequences of the Scheme.
Further details in relation to Overseas Shareholders are
contained in paragraph 18 of Part II (Explanatory Statement) of the
Scheme Document.
The Acquisition shall be subject to the applicable
requirements of the Takeover Code, the Panel, the London Stock
Exchange and the FCA.
Additional information for US
investors
The Acquisition relates to the shares of an English company
and is being made by means of a scheme of arrangement provided for
under English company law. A transaction effected by means of a
scheme of arrangement is not subject to the tender offer or proxy
solicitation rules under the US Securities Exchange Act of 1934
(the "US Exchange Act").
Accordingly, the Acquisition is subject to the disclosure
requirements and practices applicable in the United Kingdom to
schemes of arrangement which differ from the disclosure
requirements of the US tender offer and proxy solicitation
rules.
If, in the future, Aviva exercises its right to implement the
Acquisition by way of a Takeover Offer, which is to be made into
the US, such Takeover Offer will be made in compliance with the
applicable US laws and regulations, including Section 14(e) and
Regulation 14E under the US Exchange Act. Such a Takeover Offer
would be made in the US by Aviva and no one else.
It
may be difficult for US holders of Direct Line Shares to enforce
their rights and any claim arising out of the US federal securities
laws in connection with the Acquisition, since Aviva and Direct
Line are located and organised in a non-US jurisdiction, and some
or all of their officers and directors may be residents of a non-US
jurisdiction. US holders of Direct Line Shares may not be able to
sue a non-US company or its officers or directors in a non-US court
for violations of the US securities laws. Further, it may be
difficult to compel a non-US company and its affiliates to subject
themselves to a US court's judgement.
The New Aviva Shares to be issued pursuant to the Acquisition
have not been registered under the US Securities Act or under any
laws or with any securities regulatory authority of any state,
district or other jurisdiction, of the US, and may only be offered
or sold in the US in reliance on an exemption from registration
requirements of the US Securities Act including in the case of the
proposed scheme of arrangement, Section 3(a)(10) thereunder. This
announcement shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale of the
New Aviva Shares in any state of the United States in which such
offer, solicitation or sale would be unlawful prior to
qualification under the securities laws of any such state. Aviva
will rely upon the Court's sanctioning of the Scheme for the
purposes of qualifying for the exemption from the registration
requirements of the US Securities Act provided by section 3(a)(10)
thereof with respect to the New Aviva Shares to be issued pursuant
to the Scheme.
For the purposes of qualifying for the exemption from the
registration requirements of the US Securities Act afforded by
Section 3(a)(10), Direct Line will advise the Court through counsel
that Aviva will rely on the Section 3(a)(10) exemption based on the
Court's sanctioning of the Scheme, which will be relied upon by
Aviva as an approval of the Scheme following a hearing on the
fairness of the terms and conditions of the Scheme to Scheme
Shareholders, at which hearing all shareholders are entitled to
attend in person or through counsel to support or oppose the
sanctioning of the Scheme and with respect to which notification
has been given to all shareholders.
Under US securities laws, persons who are or will be deemed to
be affiliates (as defined under the US Securities Act) of Direct
Line or Aviva prior to, or of Aviva on or after, the Effective Date
may be subject to timing, manner of sale and volume restrictions on
the resale in the United States of New Aviva Shares received in
connection with the Scheme. Whether a person is an "affiliate" of a
company for such purposes depends upon the circumstances, but
affiliates of a company include individuals who, or entities that,
control directly or indirectly, or are controlled by or are under
common control with, that company, and may include certain officers
and directors and significant shareholders of Direct Line and Aviva
(typically holders of more than 10 percent of the outstanding
issued capital). Scheme Shareholders who believe they may be
affiliates for the purposes of the US Securities Act should consult
their own legal advisers prior to any resale of New Aviva Shares
received under the Scheme.
The New Aviva Shares have not been, and will not be, listed on
a US securities exchange or quoted on any inter-dealer quotation
system in the United States.
Neither the Acquisition nor this announcement nor the New
Aviva Shares to be issued pursuant to the Acquisition have been
approved or disapproved by the US Securities and Exchange
Commission, any state securities commission in the United States or
any other US regulatory authority, nor have such authorities
approved or disapproved or passed judgement upon the fairness or
the merits of the Acquisition, or determined if the information
contained in this announcement is adequate, accurate or complete.
Any representation to the contrary is a criminal offence in the
United States.
The receipt of New Aviva Shares and/or cash pursuant to the
Acquisition by a US holder as consideration for the transfer of its
Direct Line Shares pursuant to the Acquisition may be a taxable
transaction for US federal income tax purposes and under applicable
US state and local, as well as foreign and other, tax laws. Each US
holder of Direct Line Shares is urged to consult their independent
legal, tax and financial advisers regarding the tax consequences of
the Acquisition applicable to them, including under applicable US
state and local, as well as overseas and other, tax
laws.
Further details in relation to US investors are contained on
pages 43 to 45 of the Scheme Document.
Forward-looking
statements
This announcement, oral statements made regarding the
Acquisition, and other information published by Direct Line or
Aviva may contain statements about Direct Line or Aviva that are or
may be deemed to be forward looking statements. All statements
other than statements of historical facts included in this
announcement may be forward looking statements.
Without limitation, any statements preceded or followed by or
that include the words "targets", "plans", "believes", "expects",
"aims", "intends", "will", "may", "shall", "should", "anticipates",
"estimates", "projects", "is subject to", "budget", "scheduled",
"forecast" or words or terms of similar substance or the negative
thereof, are forward looking statements. Forward looking statements
include statements relating to the following: (i) the ability to
complete the Acquisition in a timely manner, (ii) future capital
expenditures, expenses, revenues, earnings, synergies, economic
performance, indebtedness, financial condition, dividend policy,
losses and future prospects; (iii) business and management
strategies and the expansion and growth of Direct Line's or Aviva's
operations and potential synergies resulting from the Acquisition;
and (iv) the effects of government regulation and/or global and/or
local economic conditions on the wider Direct Line Group's or the
wider Aviva Group's business.
Such forward looking statements are prospective in nature and
are not based on historical facts, but rather on current
expectations and projections of the management of Direct Line and
Aviva about future events, and are therefore subject to risks and
uncertainties that could significantly affect expected results and
are based on certain key assumptions. Many factors could cause
actual results to differ materially from those projected or implied
in any forward looking statements, including, but not limited to:
the impact of ongoing uncertain conditions in the global financial
markets and the national and international political and economic
situation generally (for example, in respect of the war in Ukraine
following the Russian invasion, and/or the conflict in the Middle
East), market developments and government actions, changes in or
inaccuracy of assumptions in pricing and reserving for insurance
business, particularly with regards to lapse rates and policy
renewal rates, a cyclical downturn of the insurance industry, the
impact of natural and man-made catastrophic events (including
pandemics) on Aviva's and/or Direct Line's business activities and
results of operation, the transitional, litigation and physical
risks associated with climate change, failure to understand and
respond effectively to the risks associated with sustainability,
regulatory approval of changes to the Direct Line Group's and/or
Aviva Group's internal model for calculation of regulatory capital
under the UK's version of Solvency II rules, the impact of
recognising an impairment of Direct Line's and/or Aviva's goodwill
or intangibles with indefinite lives, changes in valuation
methodologies, estimates and assumptions used in the valuation of
investment securities, the effect of legal proceedings and
regulatory investigations, the impact of operational risks,
including inadequate or failed internal and external processes,
systems and human error or from external events and malicious acts
(including cyber attack and theft, loss or misuse of customer
data), increased competition, the loss of or damage to one or more
key customer relationships, changes to habits, the outcome of
business or industry restructuring, the outcome of any litigation,
changes in global, political, social, business and economic
conditions, changes in the level of capital investment, currency
fluctuations, changes in interest and tax rates, changes in market
prices, changes in (and to interpretations of) laws, regulations or
regulatory policies, developments in legal or public policy
doctrines, technological developments, the failure to retain key
employees, or the timing and success of future offer opportunities
or major investment projects and the impact of any acquisitions or
similar transactions. Other unknown or unpredictable factors could
cause actual results to differ materially from those in the forward
looking statements.
Such forward looking statements should therefore be construed
in light of such factors. Neither Direct Line nor Aviva, nor any of
their respective associates or directors, officers or advisers,
provides any representation, assurance or guarantee that the
occurrence of the events expressed or implied in any forward
looking statements in this announcement will actually occur. Due to
such uncertainties and risks, readers are cautioned not to place
undue reliance on such forward looking statements, which speak only
as of the date hereof. All subsequent oral or written forward
looking statements attributable to any member of the Direct Line
Group or the Aviva Group, or any of their respective associates,
directors, officers, employees or advisers, are expressly qualified
in their entirety by the cautionary statement
above.
Direct Line and Aviva expressly disclaim any obligation to
update any forward looking or other statements contained herein,
except as required by applicable law or by the rules of any
competent regulatory authority, whether as a result of new
information, future events or otherwise.
No profit forecasts,
estimates or quantified financial benefits
statements
No
statement in this announcement is intended as, or is to be
construed as, a profit forecast or profit estimate for any period
and no statement in this announcement should be interpreted to mean
that earnings or earnings per Direct Line Share or Aviva Share for
the current or future financial years would necessarily match or
exceed the historical published earnings or earnings per share for
Direct Line Shares or Aviva Shares. No statement in this
announcement (including any statement of estimated costs savings or
synergies) is intended as a quantified financial benefits statement
for the purposes of the Takeover Code.
Disclosure requirements of
the Takeover Code
Under Rule 8.3(a) of the Takeover Code, any person who is
interested in 1 percent or more of any class of relevant securities
of an offeree company or of any securities exchange offeror (being
any offeror other than an offeror in respect of which it has been
announced that its offer is, or is likely to be, solely in cash)
must make an Opening Position Disclosure following the commencement
of the Offer Period and, if later, following the announcement in
which any securities exchange offeror is first identified. An
Opening Position Disclosure must contain details of the person's
interests and short positions in, and rights to subscribe for, any
relevant securities of each of (i) the offeree company and (ii) any
securities exchange offeror(s). An Opening Position Disclosure by a
person to whom Rule 8.3(a) applies must be made by no later than
3.30 p.m. (London time) on the 10th Business Day following the
commencement of the Offer Period and, if appropriate, by no later
than 3.30 p.m. (London time) on the 10th Business Day following the
announcement in which any securities exchange offeror is first
identified. Relevant persons who deal in the relevant securities of
the offeree company or of a securities exchange offeror prior to
the deadline for making an Opening Position Disclosure must instead
make a Dealing Disclosure.
Under Rule 8.3(b) of the Takeover Code, any person who is, or
becomes, interested in 1 percent or more of any class of relevant
securities of the offeree company or of any securities exchange
offeror must make a Dealing Disclosure if the person deals in any
relevant securities of the offeree company or of any securities
exchange offeror. A Dealing Disclosure must contain details of the
dealing concerned and of the person's interests and short positions
in, and rights to subscribe for, any relevant securities of each of
(i) the offeree company and (ii) any securities exchange
offeror(s), save to the extent that these details have previously
been disclosed under Rule 8. A Dealing Disclosure by a person to
whom Rule 8.3(b) applies must be made by no later than 3.30 p.m.
(London time) on the Business Day following the date of the
relevant dealing.
If
two or more persons act together pursuant to an agreement or
understanding, whether formal or informal, to acquire or control an
interest in relevant securities of an offeree company or a
securities exchange offeror, they will be deemed to be a single
person for the purpose of Rule 8.3.
Opening Position Disclosures must also be made by the offeree
company and by any offeror and Dealing Disclosures must also be
made by the offeree company, by any offeror and by any persons
acting in concert with any of them (see Rules 8.1, 8.2 and
8.4).
Details of the offeree and offeror companies in respect of
whose relevant securities Opening Position Disclosures and Dealing
Disclosures must be made can be found in the Disclosure Table on
the Panel's website at www.thetakeoverpanel.org.uk, including details of the
number of relevant securities in issue, when the Offer Period
commenced and when any offeror was first identified. You should
contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129
if you are in any doubt as to whether you are required to make an
Opening Position Disclosure or a Dealing
Disclosure.
Publication on a
website
In
accordance with Rule 26.1 of the Takeover Code, a copy of this
announcement and any document incorporated by reference will be
made available, free of charge, subject to certain restrictions
relating to persons resident in Restricted Jurisdictions, on Direct
Line's website at https://www.directlinegroup.co.uk/en/investors
and Aviva's website at
https://www.aviva.com/investors/offer-for-direct-line-insurance-group-plc/
by no later than
12.00 noon (London time) on the Business Day following the date of
this announcement.
For the avoidance of doubt, the contents of these websites are
not incorporated into, and do not form part of, this
announcement.
Right to receive documents in
hard copy form
In
accordance with Rule 30.3 of the Takeover Code, Direct Line
Shareholders, participants in the Direct Line Share Plans and
persons with information rights may request a hard copy of this
announcement, free of charge, by contacting Direct Line's
Registrars, Computershare, during business hours on +44 (0)370 873
5880, or by submitting a request in writing to The Pavilions,
Bridgwater Road, Bristol BS99 6ZY. If calling from outside of the
UK, please ensure the country code is used.
For persons who receive a copy of this announcement in
electronic form or via a website notification, a hard copy of this
announcement will not be sent unless so requested. Such persons may
also request that all future documents, announcements and
information in relation to the Acquisition are sent to them in hard
copy form.
Please note that Direct Line's Registrars, Computershare,
cannot provide advice on the merits of the Acquisition or the
Scheme or give any financial, legal or tax advice and calls may be
recorded and monitored for security and training
purposes.
Electronic
communications
Please be aware that addresses, electronic addresses and
certain other information provided by Direct Line Shareholders,
persons with information rights and other relevant persons for the
receipt of communications from Direct Line may be provided to
Aviva, members of the Aviva Group and/or their respective advisers
during the Offer Period as required under Section 4 of Appendix 4
of the Takeover Code.
General
If
you are in any doubt as to the contents of this announcement or the
action you should take, you should consult your stockbroker, bank
manager, solicitor, accountant or other independent financial
adviser who, if you are taking advice in the United Kingdom, is
authorised pursuant to FSMA or, if you are taking advice outside
the United Kingdom, is an appropriately authorised independent
professional adviser.